| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| ALNYAlnylam Pharmaceuticals, Inc. | 44.07B | 332.92 | 142.88 | 65.19% | 8.45% | 39.76% | 1.06% | 3.76 |
| SLXNWSilexion Therapeutics Ltd. | 63.6M | 0.03 | 0.00 | -132.54% | ||||
| EDITEditas Medicine, Inc. | 205.18M | 2.20 | -0.76 | -58.64% | -430.84% | -14.85% | 0.26 | |
| SGMOSangamo Therapeutics, Inc. | 92.01M | 0.43 | -0.88 | -67.2% | -331.28% | -17.44% | 1.34 | |
| CAMPCAMP4 Therapeutics Corporation | 210.49M | 4.49 | -1.69 | 86.29% | -14.04% | -133.54% | 0.14 | |
| SLNSilence Therapeutics plc | 256.95M | 5.44 | -1.71 | 70.47% | -252.16% | -84.61% | 0.00 | |
| PEPGPepGen Inc. | 202.89M | 6.22 | -2.18 | -57.35% | 0.16 | |||
| ARCTArcturus Therapeutics Holdings Inc. | 224.14M | 8.23 | -2.74 | -12.27% | -72.48% | -29.71% | 0.12 |
Analyze head-to-head performance against top industry competitors across valuation, growth, and profitability metrics.
| Sep 2016 | Sep 2017 | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 158.33K | 31.41M | 16.14M | 168.8M | 87.99M | 138.29M | 243.23M | 240.74M | 3.55M | 829.45M |
| Revenue Growth % | -58.55% | 19736.49% | -48.6% | 945.67% | -47.87% | 57.16% | 75.89% | -1.03% | -98.52% | 23258.15% |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23.93M |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | 2.88% |
| Gross Profit | 0 | 0 | 0 | 0 | 87.99M | 138.29M | 243.23M | 240.74M | 3.55M | 805.52M |
| Gross Margin % | - | - | - | - | 100% | 100% | 100% | 100% | 100% | 97.12% |
| Gross Profit Growth % | - | - | - | - | - | 57.16% | 75.89% | -1.03% | -98.52% | 22584.31% |
| Operating Expenses | 79.85M | 68.4M | 72.08M | 107.61M | 181.15M | 287.32M | 421.74M | 445.74M | 604.63M | 707.17M |
| OpEx % of Revenue | 50431.84% | 217.79% | 446.52% | 63.75% | 205.87% | 207.77% | 173.39% | 185.16% | 17027.06% | 85.26% |
| Selling, General & Admin | 23.59M | 17.5M | 19.11M | 26.56M | 52.28M | 80.98M | 124.43M | 90.93M | 96.82M | 123.94M |
| SG&A % of Revenue | 14902.07% | 55.72% | 118.38% | 15.73% | 59.41% | 58.56% | 51.16% | 37.77% | 2726.56% | 14.94% |
| Research & Development | 62.12M | 50.9M | 52.97M | 81.05M | 128.88M | 206.34M | 297.31M | 353.19M | 505.87M | 607.16M |
| R&D % of Revenue | 39232.39% | 162.08% | 328.13% | 48.02% | 146.46% | 149.21% | 122.23% | 146.71% | 14245.85% | 73.2% |
| Other Operating Expenses | -5.86M | 0 | 0 | 0 | 0 | 0 | 0 | 1.62M | 1.94M | -23.93M |
| Operating Income | -81.74M | -37M | -55.94M | 61.19M | -93.16M | -149.04M | -178.51M | -205M | -601.08M | 98.35M |
| Operating Margin % | -51627.09% | -117.79% | -346.52% | 36.25% | -105.87% | -107.77% | -73.39% | -85.16% | -16927.06% | 11.86% |
| Operating Income Growth % | 14.83% | 54.74% | -51.2% | 209.39% | -252.24% | -59.98% | -19.77% | -14.84% | -193.21% | 116.36% |
| EBITDA | -78.48M | -32.31M | -51.24M | 65.63M | -87.22M | -140.77M | -168.09M | -192.51M | -582.49M | 122.27M |
| EBITDA Margin % | -49568.11% | -102.86% | -317.41% | 38.88% | -99.12% | -101.79% | -69.11% | -79.97% | -16403.41% | 14.74% |
| EBITDA Growth % | 16.18% | 58.84% | -58.6% | 228.09% | -232.89% | -61.4% | -19.41% | -14.53% | -202.58% | 120.99% |
| D&A (Non-Cash Add-back) | 3.26M | 4.69M | 4.7M | 4.44M | 5.94M | 8.27M | 10.42M | 12.49M | 18.59M | 23.93M |
| EBIT | -79.69M | -37M | -55.94M | 61.19M | -93.16M | -140.85M | -172.71M | -188.16M | -580.11M | 140.89M |
| Net Interest Income | 265.79K | 415.13K | 1.05M | 6.96M | 9.19M | 6.12M | 5.03M | -3.03M | -9.63M | -52.07M |
| Interest Income | 265.79K | 415.13K | 1.05M | 6.96M | 9.19M | 6.12M | 5.03M | 15.3M | 22.72M | 37.29M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18.33M | 32.35M | 89.36M |
| Other Income/Expense | 22.12K | 2.62M | 1.49M | 6.96M | 8.61M | 8.19M | 5.8M | -1.49M | -11.38M | -46.81M |
| Pretax Income | -81.72M | -34.38M | -54.45M | 68.15M | -84.55M | -140.85M | -172.71M | -206.49M | -612.46M | 51.53M |
| Pretax Margin % | -51613.12% | -109.46% | -337.3% | 40.37% | -96.09% | -101.85% | -71.01% | -85.78% | -17247.54% | 6.21% |
| Income Tax | 2.4K | 2.4K | 2.4K | 174K | 2K | 2K | 3.79M | 2.78M | -2.77M | 21.42M |
| Effective Tax Rate % | 100% | 100.01% | 100% | 99.74% | 100% | 100% | 101.94% | 99.41% | 97.88% | -3.16% |
| Net Income | -81.72M | -34.38M | -54.45M | 67.97M | -84.55M | -140.85M | -176.06M | -205.28M | -599.49M | -1.63M |
| Net Margin % | -51614.63% | -109.46% | -337.31% | 40.27% | -96.09% | -101.85% | -72.39% | -85.27% | -16882.37% | -0.2% |
| Net Income Growth % | 11.11% | 57.93% | -58.38% | 224.84% | -224.39% | -66.58% | -25% | -16.59% | -192.04% | 99.73% |
| Net Income (Continuing) | -81.72M | -34.38M | -54.45M | 67.97M | -84.55M | -140.85M | -176.49M | -209.28M | -609.69M | 30.11M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -555.19K | -555.19K | -555.19K | -555.19K | 0 | 0 | 19.82M | 15.82M | 5.62M | 37.36M |
| EPS (Diluted) | -1.34 | -0.47 | -0.65 | 0.69 | -0.84 | -1.36 | -1.67 | -1.92 | -5.00 | -0.01 |
| EPS Growth % | 16.25% | 64.93% | -38.3% | 206.15% | -221.74% | -61.9% | -22.79% | -14.97% | -160.42% | 99.76% |
| EPS (Basic) | -1.34 | -0.47 | -0.65 | 0.72 | -0.84 | -1.36 | -1.67 | -1.91 | -5.00 | -0.01 |
| Diluted Shares Outstanding | 61.05M | 73.9M | 83.64M | 98.61M | 100.72M | 103.75M | 105.43M | 106.75M | 119.78M | 133.76M |
| Basic Shares Outstanding | 60.99M | 73.15M | 83.64M | 93.86M | 100.72M | 103.75M | 105.43M | 107.31M | 119.78M | 133.76M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Sep 2016 | Sep 2017 | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 90.5M | 67.9M | 78.77M | 265.25M | 322.37M | 384.6M | 405.3M | 419.52M | 695.47M | 950.64M |
| Cash & Short-Term Investments | 85.37M | 65.61M | 76.53M | 258.7M | 315.49M | 367.79M | 376.4M | 403.63M | 680.96M | 919.37M |
| Cash Only | 85.37M | 24.84M | 30.13M | 221.8M | 143.58M | 184.43M | 108M | 110.89M | 102.69M | 226.55M |
| Short-Term Investments | 0 | 40.77M | 46.4M | 36.9M | 171.91M | 183.35M | 268.39M | 292.74M | 578.28M | 692.82M |
| Accounts Receivable | 75K | 67.8K | 327.38K | 661.36K | 845.67K | 10.26M | 1.41M | 0 | 0 | 6.82M |
| Days Sales Outstanding | 172.9 | 0.79 | 7.4 | 1.43 | 3.51 | 27.07 | 2.12 | - | - | 3 |
| Inventory | 1.29M | 867.36K | 1.27M | 3.32M | 4.25M | 4.36M | -21.61M | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 3.77M | 1.36M | 640.12K | -754.57K | -2.47M | -2.17M | 41.82M | 7.08M | 4.97M | 13.52M |
| Total Non-Current Assets | 37.67M | 36.12M | 32.84M | 84.6M | 200.13M | 325.55M | 286.64M | 346.03M | 444.33M | 499.8M |
| Property, Plant & Equipment | 15.39M | 15.51M | 13.94M | 23.21M | 47.02M | 66.02M | 168.59M | 335.56M | 431.29M | 426.41M |
| Fixed Asset Turnover | 0.01x | 2.02x | 1.16x | 7.27x | 1.87x | 2.09x | 1.44x | 0.72x | 0.01x | 1.95x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 22.16M | 20.46M | 18.76M | 17.06M | 15.36M | 13.66M | 11.96M | 10.26M | 8.56M | 6.86M |
| Long-Term Investments | 0 | 0 | 0 | 44.18M | 137.49M | 245.59M | 105.87M | 0 | 0 | 0 |
| Other Non-Current Assets | 122.33K | 141.92K | 141.92K | 144.15K | 265.36K | 272K | 218K | 210K | 4.48M | 1.39M |
| Total Assets | 128.18M | 104.02M | 111.61M | 349.85M | 522.5M | 710.15M | 691.94M | 765.55M | 1.14B | 1.45B |
| Asset Turnover | 0.00x | 0.30x | 0.14x | 0.48x | 0.17x | 0.19x | 0.35x | 0.31x | 0.00x | 0.57x |
| Asset Growth % | -3.09% | -18.84% | 7.29% | 213.45% | 49.35% | 35.91% | -2.56% | 10.64% | 48.89% | 27.25% |
| Total Current Liabilities | 25.64M | 18.7M | 12.36M | 97.07M | 40.68M | 146.54M | 138.85M | 105.46M | 103.17M | 195.49M |
| Accounts Payable | 12.23M | 4.08M | 2.81M | 7.65M | 6.83M | 9.46M | 2.87M | 35.87M | 11.39M | 17.67M |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | 269.6 |
| Short-Term Debt | 194.31K | 208.51K | 223.82K | 0 | 1.09M | 2.25M | 2.78M | 10.56M | 6.34M | 40M |
| Deferred Revenue (Current) | 3.01M | 5.71M | 600 | 77.77M | 19.29M | 111.06M | 74.1M | 866K | 0 | 2.4M |
| Other Current Liabilities | 6.24M | 5.31M | 5.4M | 6.7M | 5.41M | 14M | 46.86M | 40.2M | 63.45M | 80.43M |
| Current Ratio | 3.53x | 3.63x | 6.37x | 2.73x | 7.92x | 2.62x | 2.92x | 3.98x | 6.74x | 4.86x |
| Quick Ratio | 3.48x | 3.58x | 6.27x | 2.70x | 7.82x | 2.59x | 3.07x | 3.98x | 6.74x | 4.86x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 7.51M | 4.45M | 4M | 8.74M | 20.04M | 154.79M | 134.75M | 372.93M | 845.57M | 751.53M |
| Long-Term Debt | 2.53M | 2.33M | 2.1M | 0 | 0 | 0 | 0 | 268.33M | 734.54M | 582.28M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 20.04M | 23.3M | 78.8M | 104.61M | 111.03M | 104.11M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 65.14M |
| Other Non-Current Liabilities | 2.47M | 2.13M | 1.9M | 3.7M | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 33.15M | 23.16M | 16.37M | 105.81M | 60.72M | 301.33M | 273.6M | 478.39M | 948.74M | 947.02M |
| Total Debt | 2.73M | 2.53M | 2.33M | 0 | 21.14M | 25.55M | 81.58M | 383.5M | 851.91M | 837.79M |
| Net Debt | -82.64M | -22.31M | -27.81M | -221.8M | -122.44M | -158.89M | -26.43M | 272.61M | 749.23M | 611.25M |
| Debt / Equity | 0.03x | 0.03x | 0.02x | - | 0.05x | 0.06x | 0.20x | 1.34x | 4.46x | 1.66x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | 6.85x |
| Net Debt / EBITDA | - | - | - | -3.38x | - | - | - | - | - | 5.00x |
| Interest Coverage | - | - | - | - | - | - | - | -11.19x | -18.58x | 1.10x |
| Total Equity | 95.02M | 80.87M | 95.24M | 244.04M | 461.78M | 408.82M | 418.34M | 287.16M | 191.06M | 503.42M |
| Equity Growth % | -13.32% | -14.9% | 17.77% | 156.23% | 89.23% | -11.47% | 2.33% | -31.36% | -33.47% | 163.48% |
| Book Value per Share | 1.56 | 1.09 | 1.14 | 2.47 | 4.58 | 3.94 | 3.97 | 2.69 | 1.60 | 3.76 |
| Total Shareholders' Equity | 95.58M | 81.42M | 95.8M | 244.59M | 461.78M | 408.82M | 398.52M | 271.34M | 185.44M | 466.05M |
| Common Stock | 162.12K | 167.16K | 180.88K | 187.88K | 194.75K | 197K | 198K | 200K | 217K | 231K |
| Retained Earnings | -398.44M | -432.82M | -487.27M | -419.29M | -503.84M | -644.69M | -820.75M | -1.03B | -1.63B | -1.63B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -53.19M |
| Accumulated OCI | 7.45K | 33.23K | -21.56K | -391.62K | 18.43K | -69K | -136K | -3.22M | 4.75M | 6.44M |
| Minority Interest | -555.19K | -555.19K | -555.19K | -555.19K | 0 | 0 | 19.82M | 15.82M | 5.62M | 37.36M |
| Sep 2016 | Sep 2017 | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -64.43M | -23.94M | -47.22M | 173.03M | -95.39M | 171.22M | -136.13M | -153.89M | -462.85M | 179.55M |
| Operating CF Margin % | -40691.13% | -76.22% | -292.54% | 102.51% | -108.41% | 123.82% | -55.97% | -63.93% | -13034.38% | 21.65% |
| Operating CF Growth % | 1.95% | 62.84% | -97.27% | 466.42% | -155.13% | 279.5% | -179.5% | -13.05% | -200.77% | 138.79% |
| Net Income | -81.72M | -34.38M | -54.45M | 67.97M | -84.55M | -140.85M | -176.49M | -209.28M | -609.69M | 30.11M |
| Depreciation & Amortization | 3.26M | 4.69M | 4.7M | 4.44M | 5.94M | 8.27M | 10.42M | 12.49M | 18.59M | 23.93M |
| Stock-Based Compensation | 11.6M | 7.89M | 8.45M | 12.39M | 43.38M | 76.67M | 120.89M | 78.13M | 73.97M | 63.37M |
| Deferred Taxes | 2.35M | -890.36K | -432.14K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -5.63M | -43.52K | 383.07K | 1.07M | 525.29K | 266K | 7.34M | 16.31M | 29.19M | 80.38M |
| Working Capital Changes | 5.72M | -1.21M | -5.88M | 87.16M | -60.69M | 226.87M | -98.29M | -51.55M | 25.09M | -18.23M |
| Change in Receivables | -75K | 7.2K | -259.58K | -333.99K | -184.31K | -9.41M | 8.85M | 1.41M | 0 | -56.97M |
| Change in Inventory | -1.89M | 2.41M | 1.34M | -1.26M | 1.6M | 9.16M | 0 | 0 | 0 | 0 |
| Change in Payables | 2.55M | -3.51M | -1.27M | 4.84M | -821.01K | 2.63M | -6.59M | 33M | -5.54M | 6.29M |
| Cash from Investing | 13.45M | -48.64M | -7.43M | -47.75M | -240.78M | -141.68M | -5.42M | -96.16M | -420.07M | -129.29M |
| Capital Expenditures | -3.86M | -7.92M | -1.42M | -12M | -11.95M | -23.57M | -52.78M | -176.74M | -141.47M | -22.67M |
| CapEx % of Revenue | 2438.05% | 25.21% | 8.8% | 7.11% | 13.58% | 17.04% | 21.7% | 73.42% | 3983.92% | 2.73% |
| Acquisitions | 0 | 0 | 7.43B | 47.75B | 240.78B | 141.68M | -47.36M | -80.58M | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 17.31M | -40.73M | -7.43B | -47.75B | -240.78B | -141.68M | 47.36M | 80.58M | 0 | 0 |
| Cash from Financing | 55.13M | 12.06M | 59.95M | 66.38M | 257.95M | 11.3M | 65.19M | 253.05M | 870.52M | 74.01M |
| Debt Issued (Net) | -217.55K | -197.79K | -208.51K | -2.42M | 0 | 0 | 0 | 250M | 392M | -196.37M |
| Equity Issued (Net) | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 3.12M | -166.02K | 3.58M | 8.28M | 0 | 0 | 60M | 0 | 49.26M | 0 |
| Net Change in Cash | 4.15M | -60.53M | 5.29M | 191.67M | -78.22M | 40.85M | -76.43M | 2.89M | -8.21M | 124.26M |
| Free Cash Flow | -68.29M | -31.86M | -48.64M | 161.03M | -107.34M | 147.66M | -188.91M | -330.63M | -604.32M | 156.89M |
| FCF Margin % | -43129.18% | -101.43% | -301.35% | 95.4% | -121.99% | 106.78% | -77.67% | -137.34% | -17018.3% | 18.91% |
| FCF Growth % | -0.9% | 53.35% | -52.7% | 431.04% | -166.66% | 237.56% | -227.94% | -75.02% | -82.78% | 125.96% |
| FCF per Share | -1.12 | -0.43 | -0.58 | 1.63 | -1.07 | 1.42 | -1.79 | -3.10 | -5.05 | 1.17 |
| FCF Conversion (FCF/Net Income) | 0.79x | 0.70x | 0.87x | 2.55x | 1.13x | -1.22x | 0.77x | 0.75x | 0.77x | -110.09x |
| Interest Paid | 11.29K | 187.65K | 173.38K | 27K | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 2.4K | 2.4K | 2.4K | 302K | 0 | 2K | 2K | 0 | 3.74M | 0 |
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -79.87% | -39.09% | -61.84% | 40.07% | -23.96% | -32.36% | -42.57% | -58.19% | -250.72% | -0.47% |
| Return on Invested Capital (ROIC) | -295.09% | -78.22% | -66.59% | 102.37% | -38.65% | -37.94% | -41.72% | -32.31% | -60.11% | 7.18% |
| Gross Margin | - | - | - | - | 100% | 100% | 100% | 100% | 100% | 97.12% |
| Net Margin | -51614.63% | -109.46% | -337.31% | 40.27% | -96.09% | -101.85% | -72.39% | -85.27% | -16882.37% | -0.2% |
| Debt / Equity | 0.03x | 0.03x | 0.02x | - | 0.05x | 0.06x | 0.20x | 1.34x | 4.46x | 1.66x |
| Interest Coverage | - | - | - | - | - | - | - | -11.19x | -18.58x | 1.10x |
| FCF Conversion | 0.79x | 0.70x | 0.87x | 2.55x | 1.13x | -1.22x | 0.77x | 0.75x | 0.77x | -110.09x |
| Revenue Growth | -58.55% | 19736.49% | -48.6% | 945.67% | -47.87% | 57.16% | 75.89% | -1.03% | -98.52% | 23258.15% |
Explore detailed financial history, valuation models, and returns analysis
DCF models, peer multiples & analyst estimates
Historical returns with dividends reinvested
Yield, growth, payout safety & DRIP calculator
EPS trends, net income & profitability analysis
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of valuation, profitability & efficiency metrics